preview

Clinical Drug Testing

Decent Essays

The question of today is this; should people who are life threateningly ill be allowed direct access to possibly lifesaving but experimental drugs? The topic is a very debatable one with great points for both sides. On one side, it is terrible to experiment on humans, but on the other hand, it could save them, and the effects of not testing could be deadly. It is a matter of life and death for some people. I believe that people who are life threateningly ill should be allowed to have direct access to experimental drugs not approved by the FDA because they are already dying, it may save others’ lives, and the only other way for them to get the drugs are through clinical trials, which are in limited availability. I will talk more in depth about …show more content…

The clinical trials, while beneficial by the scientific method are unfair to the control group. For example, participation in the AIDS clinical drug trials meant that patients hat a chance of being put into the placebo control group, the group not being given the experimental drug. The patients understood the steep odds of the drug not working, but there was still a chance. The same could not be said for the placebos (IFL Science). Getting the drugs from the companies would be much more helpful and ensure everyone gets a chance. A large pool of patients who can’t get access to the clinical trials can get access if the company files an Investigational New Drug application, a treatment known as IND which requires less red tape than an individual request, but it also requires more data tracking. A medium sized group ranging between 10 and 100 patients, can qualify through a middle ground, that means less work for patients than an individual application and fewer data requirements for companies (oxford). This presents a way for more people to get to try aside from the clinical trials. On rare occasions, the drug is released on compassionate grounds, but that doesn’t always happen (IFL Science). I believe there should be more of these. The starts of the clinical trials — known as phase I — are made to check for safety, major side effects, and determine the best amount of a drug to use. These studies involve only a small number of people (healthline). “When you have promising drugs that are showing efficacy and safety in early clinical trials, we need those drugs approved earlier,” said Burroughs. “That’s the way to help the vast majority of people who’ve run out of FDA options and can’t get into clinical trials.” (healthline). The clinical trials are in limited supply and not fair to all who

Get Access